BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32883514)

  • 1. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction.
    Kaing A; Jaswa EA; Diamond MP; Legro RS; Cedars MI; Huddleston HG
    Fertil Steril; 2021 Feb; 115(2):438-446. PubMed ID: 32883514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated antimüllerian hormone levels are not associated with preterm delivery after in vitro fertilization or ovulation induction.
    Kim AE; Simoni MK; Nadgauda A; Koelper N; Dokras A
    Fertil Steril; 2023 Nov; 120(5):1013-1022. PubMed ID: 37495009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome.
    Hu KL; Liu FT; Xu H; Li R; Qiao J
    Fertil Steril; 2020 Feb; 113(2):444-452.e1. PubMed ID: 31973904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome.
    Du M; Zhang J; Yu X; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():788000. PubMed ID: 34956097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin.
    Komorowski AS; Hughes L; Sarkar P; Aaby DA; Kumar A; Kalra B; Legro RS; Boots CE
    Fertil Steril; 2024 Apr; 121(4):660-668. PubMed ID: 38154770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome.
    Hsu JY; James KE; Bormann CL; Donahoe PK; Pépin D; Sabatini ME
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4187-4196. PubMed ID: 30239805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
    Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
    Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
    Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
    Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.
    Mumford SL; Legro RS; Diamond MP; Coutifaris C; Steiner AZ; Schlaff WD; Alvero R; Christman GM; Casson PR; Huang H; Santoro N; Eisenberg E; Zhang H; Cedars MI
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3288-96. PubMed ID: 27228369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin.
    Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ
    Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-Müllerian hormone percentile.
    Arslanca T; Ecemis T; Kiseli M; Arslanoglu E; Kotanoğlu MS; Caglar GS
    J Obstet Gynaecol; 2022 Jul; 42(5):1319-1324. PubMed ID: 34698605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.
    Liu S; Hong L; Mo M; Xiao S; Wang X; Fan X; Zhang S; Diao L; Zeng Y
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):171. PubMed ID: 35236324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
    Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome.
    Köninger A; Kampmeier A; Schmidt B; Frank M; Strowitzki T; Kimmig R; Gellhaus A; Mach P
    Reprod Biomed Online; 2018 Sep; 37(3):367-374. PubMed ID: 30146442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.
    Piltonen TT; Giacobini P; Edvinsson Å; Hustad S; Lager S; Morin-Papunen L; Tapanainen JS; Sundström-Poromaa I; Arffman RK
    Fertil Steril; 2019 Mar; 111(3):588-596.e1. PubMed ID: 30630591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.